Redir

Thursday, February 24, 2011

Early safety results promising for Phase I/II trial of gene therapy treatment of hemophilia B

Vector-gene combination developed at St. Jude Children�"s Research Hospital and UCL is central to latest clinical trial of gene therapy as a possible tool to provide long-term relief from disabling bleeds
Read More...
[Source: St. Jude Children's Research Hospital - Latest News]

No comments:

Post a Comment